IMGO实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (11 Jan 2023 @ 05:00):

Stats
今日成交量	138 127
平均成交量	762 778
市值	0.00
EPS	$-0.500 ( 2022-11-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.674 (1.87%)

Insider Trading

Date	Person	Action	Amount	type
2023-01-11	Keating Laurie	Sell	11 904	Stock Option (Right to Buy)
2023-01-11	Kariuki Enoch	Sell	11 904	Stock Option (Right to Buy)
2023-01-11	Tapper Amy E.	Sell	141 094	Common Stock
2023-01-11	Tapper Amy E.	Sell	103 000	Stock Option (Right to Buy)
2023-01-11	Rienhoff Hugh Jr	Sell	501 702	Common Stock

INSIDER POWER
-50.69
Last 100 transactions
Buy: 1 323 458 \| Sell: 3 917 808

音量相关性

長: 0.25 (neutral)

短: 0.21 (neutral)

Signal:(86.307) Neutral

Imago BioSciences, Inc. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Imago BioSciences, Inc. 相关性 - 货币/商品

0.26
( neutral )

0.55
( weak )

0.58
( weak )

0.73
( moderate )

-0.62
( weak negative )

-0.19
( neutral )

Imago BioSciences, Inc. 财务报表

Annual	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-3.16

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-3.16

FY	2020
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.330

FY	2019
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.815

Financial Reports:

No articles found.

Imago BioSciences, Inc.

Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.